LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 65.12 | 17.25 | 2 | 5095 | 0.0004 | -0.2309 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 65.12 | 17.25 | 9473 | 5095 | 1.8592 | 1.1570 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 65.12 | 17.25 | 2 | 5095 | 0.0004 | -0.2309 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 65.12 | 17.25 | 9113 | 5095 | 1.7885 | 1.1468 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 67.09 | 17.25 | 6 | 5221 | 0.0011 | -0.1203 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 67.09 | 17.25 | 9865 | 5221 | 1.8895 | 1.1605 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 67.09 | 17.25 | 2 | 5221 | 0.0004 | -0.2301 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 67.09 | 17.25 | 9365 | 5221 | 1.7937 | 1.1469 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 69.06 | 17.25 | 2 | 5242 | 0.0004 | -0.2299 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 69.06 | 17.25 | 10115 | 5242 | 1.9294 | 1.1659 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 69.06 | 17.25 | 2 | 5242 | 0.0004 | -0.2299 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 69.06 | 17.25 | 9793 | 5242 | 1.8680 | 1.1574 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 71.03 | 17.25 | 1 | 5367 | 0.0002 | -0.2910 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 71.03 | 17.25 | 10493 | 5367 | 1.9551 | 1.1686 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 71.03 | 17.25 | 1 | 5367 | 0.0002 | -0.2910 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 71.03 | 17.25 | 10019 | 5367 | 1.8668 | 1.1566 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 73.00 | 17.25 | 2 | 5546 | 0.0004 | -0.2280 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 73.00 | 17.25 | 10742 | 5546 | 1.9366 | 1.1652 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 73.00 | 17.25 | 1 | 5546 | 0.0002 | -0.2896 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 73.00 | 17.25 | 10411 | 5546 | 1.8769 | 1.1571 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 74.97 | 17.25 | 4 | 5618 | 0.0007 | -0.1606 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 74.97 | 17.25 | 11050 | 5618 | 1.9666 | 1.1688 | MN20160310_N02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 74.97 | 17.25 | 5 | 5618 | 0.0009 | -0.1379 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 74.97 | 17.25 | 10687 | 5618 | 1.9020 | 1.1601 | MN20160310_N02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 76.94 | 17.25 | 2 | 5681 | 0.0004 | -0.2271 | MN20160310_N02 | L17 |